Related Experiment Video

Updated: May 26, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma

Yuan Tian1, Yang Nan, Lei Han

  • 1Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, PR China.

International Journal of Oncology
|December 20, 2011
PubMed

Insights

MicroRNA miR-451 is downregulated in gliomas and suppresses tumor growth. This study identified CAB39 as a direct target, revealing miR-451

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA miR-451 is frequently downregulated in gliomas.
  • Previous studies indicate miR-451 inhibits glioma cell growth, proliferation, and induces apoptosis.
  • The precise molecular mechanisms underlying miR-451's tumor-suppressive role require further elucidation.

Purpose of the Study:

  • To identify a direct target gene of miR-451 in human glioma.
  • To investigate the mechanism by which miR-451 exerts its glioma-suppressive effects.
  • To validate the role of miR-451 in glioma progression both in vitro and in vivo.

Main Methods:

  • Quantitative real-time PCR and fluorescence in situ hybridization for miR-451 expression analysis.
  • Transfection of human glioma cell lines with miR-451 mimics.
  • In vivo subcutaneous tumor assays in nude mice.
  • Western blotting and luciferase reporter assays to identify and validate target genes and pathways.

Main Results:

  • miR-451 expression was significantly downregulated in glioma tissues and inversely correlated with WHO tumor grades.
  • In vivo assays confirmed the tumor-suppressive function of miR-451.
  • CAB39 was confirmed as a direct target gene of miR-451 via luciferase reporter assays.
  • Western blot analysis revealed significant alterations in PI3K/AKT pathway factors.

Conclusions:

  • miR-451 functions as a tumor suppressor in glioma, both in vitro and in vivo.
  • miR-451 directly targets CAB39, leading to indirect inhibition of the PI3K/AKT pathway.
  • Restoring miR-451 expression represents a potential therapeutic strategy for glioma treatment.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...